Case Reports in Gastrointestinal Medicine

Case Reports in Gastrointestinal Medicine / 2018 / Article

Case Report | Open Access

Volume 2018 |Article ID 5714053 | 2 pages | https://doi.org/10.1155/2018/5714053

Spontaneous Bacterial Peritonitis due to Lactobacillus paracasei in Cirrhosis

Academic Editor: Hideto Kawaratani
Received28 Nov 2017
Accepted05 Feb 2018
Published01 Mar 2018

Abstract

Lactobacillus species colonize the human gastrointestinal tract and are rarely pathogenic. We present a case involving a cirrhotic patient who presented with sepsis and was found to have peritoneal cultures demonstrating Lactobacillus as the sole pathogen concerning for spontaneous bacterial peritonitis. Treatment was achieved with high-dose penicillin and clindamycin but the patient developed hepatorenal syndrome and died from acute renal failure. Intra-abdominal Lactobacillus infections are typically seen in patients undergoing peritoneal dialysis or who have recently had bowel perforation. There are few case reports of spontaneous Lactobacillus peritonitis in patients with cirrhosis. Our case report addresses the challenges of Lactobacillus treatment and suggests antibiotic coverage of commensal organisms in patients who do not improve with standard management.

1. Introduction

Lactobacillus species are facultative anaerobic gram-positive bacilli that are part of normal human gastrointestinal flora and are seldom pathogenic [1]. We present a rare case of spontaneous Lactobacillus peritonitis in a cirrhotic patient which illustrates the importance of early microbiologic studies in patients with spontaneous bacterial peritonitis unresponsive to empiric antibiotic therapy.

2. Case Presentation

A 73-year-old male with alcoholic cirrhosis complicated by prior spontaneous bacterial peritonitis on ciprofloxacin prophylaxis presented to the emergency department with fever, abdominal pain, and nausea. On admission he had normal vital signs. His abdomen was distended and diffusely tender with a positive fluid wave. Laboratory results revealed a leukocytosis to 18,200 cells/mL, stable liver function tests, and a creatinine of 1.8 mg/dL. His Model for End-Stage Liver Disease (MELD) score was 18 on initial presentation. Paracentesis revealed hazy peritoneal fluid with 2,590 white blood cells of which 2,434 were neutrophils. He was started on vancomycin and ertapenem for sepsis secondary to spontaneous bacterial peritonitis but progressively worsened clinically. On day 4 of hospitalization, the patient became tachycardic and hypotensive with a leukocytosis of 29,900 cells/mL. Repeat paracentesis revealed 2,670 neutrophils. A CT scan of the abdomen did not show evidence of focal infection or gastrointestinal perforation. Peritoneal fluid cultures revealed Lactobacillus paracasei as the sole pathogen isolated from both aerobic and anaerobic plates. The isolate was resistant to carbapenems and sensitive to clindamycin and penicillin. The patient was switched to clindamycin and high-dose intravenous penicillin (2 million units every 4 hours) for Lactobacillus coverage. Despite a rapid improvement in his peripheral leukocytosis and hemodynamic measures, the patient’s creatinine continued to rise rapidly. He ultimately developed type 2 hepatorenal syndrome with anuric renal failure. He was transitioned to comfort care and died of multiorgan failure.

3. Discussion

Lactobacillus species are rarely implicated in spontaneous abdominal infections. Previous case reports describe secondary Lactobacillus peritonitis in the setting of peritoneal dialysis, recent intra-abdominal surgery, or gastrointestinal perforation [26]. Spontaneous Lactobacillus peritonitis in the absence of these risk factors is exceptionally rare and has exclusively been reported in severe decompensated cirrhosis with ascites [2, 7]. Given the impairment of intestinal barrier function and relative immunodeficiency created by cirrhosis, spontaneous Lactobacillus peritonitis most likely represents seeding of ascites via transmural migration across the bowel wall. Importantly, Lactobacillus is unusual in that it is intrinsically resistant to vancomycin and commonly resistant to cephalosporins [1]. As a result, infection with Lactobacillus is unlikely to respond to empiric antibiotic choices for spontaneous bacterial peritonitis. The most widely studied treatment for Lactobacillus peritonitis is high-dose intravenous penicillin (12–20 million units per day) in combination with aminoglycoside or clindamycin [8].

The clinical significance of Lactobacillus spp. cultured from sterile sites has been widely debated, and certainly not all cultures are indicative of true infection [9]. When Lactobacillus is cultured in the setting of abdominal viscus perforation, cultures are typically polymicrobial [2]. Our patient had a large neutrophilic predominance in his ascitic fluid with cultures growing only a single Lactobacillus isolate. Lactobacillus paracasei was identified in our microbiology laboratory with a gram stain revealing slender gram-positive rods in chains and after forming alpha-hemolytic colonies on blood agar which were hydrogen sulfide and catalase negative. The frequency of this clinical entity may be underrecognized, as Lactobacilli exhibit variable gram stain morphology and minimal growth on typical media [10]. Our patient responded dramatically to appropriate therapy with both clinical and symptomatic improvement. It may therefore be appropriate to broaden empiric treatment to cover Lactobacillus in patients not responding to typical gram-negative coverage. While clinically significant infection with Lactobacillus is rare, this case underlines the importance of early recognition and treatment of atypical pathogens in patients presenting with spontaneous bacterial peritonitis and cirrhosis.

Conflicts of Interest

The authors declare that there are no conflicts of interest regarding the publication of this article.

References

  1. J. P. Cannon, T. A. Lee, J. T. Bolanos, and L. H. Danziger, “Pathogenic relevance of Lactobacillus: A retrospective review of over 200 cases,” European Journal of Clinical Microbiology & Infectious Diseases, vol. 24, no. 1, pp. 31–40, 2005. View at: Publisher Site | Google Scholar
  2. S.-Y. Lee, C.-T. Chang, M.-H. Lee, and M.-S. Wu, “Lactobacillus peritonitis: A rare cause of peritonitis in peritoneal dialysis patients,” Renal Failure, vol. 26, no. 4, pp. 419–423, 2004. View at: Publisher Site | Google Scholar
  3. C. R. Schleifer, R. L. Benz, R. McAlack, J. Poupard, and J. Calmon, “Lactobacillus acidophilus peritonitis in CAPD,” Peritoneal Dialysis International, vol. 9, no. 3, pp. 222-223, 1989. View at: Google Scholar
  4. D. Sanyal and S. Bhandari, “CAPD peritonitis caused by Lactobacillus rhamnosus,” Journal of Hospital Infection, vol. 22, no. 4, pp. 325–327, 1992. View at: Publisher Site | Google Scholar
  5. G. Klein, E. Zill, R. Schindler, and J. Louwers, “Peritonitis associated with vancomycin-resistant Lactobacillus rhamnosus in a continuous ambulatory peritoneal dialysis patient: Organism identification, antibiotic therapy, and case report,” Journal of Clinical Microbiology, vol. 36, no. 6, pp. 1781–1783, 1998. View at: Google Scholar
  6. P. A. Neef, H. Polenakovik, J. E. Clarridge, M. Saklayen, L. Bogard, and J. M. Bernstein, “Lactobacillus paracasei, continuous ambulatory peritoneal dialysis-related peritonitis and review of the literature,” Journal of Clinical Microbiology, vol. 41, no. 6, pp. 2783-2784, 2003. View at: Publisher Site | Google Scholar
  7. M. K. Salminen, H. Rautelin, S. Tynkkynen et al., “Lactobacillus Bacteremia, Clinical Significance, and Patient Outcome, with Special Focus on Probiotic L. Rhamnosus GG,” Clinical Infectious Diseases, vol. 38, no. 1, pp. 62–69, 2004. View at: Publisher Site | Google Scholar
  8. S. J. Antony, “Lactobacillemia: An emerging cause of infection in both the immunocompromised and the immunocompetent host,” Journal of the National Medical Association, vol. 92, no. 2, pp. 83–86, 2000. View at: Google Scholar
  9. R. N. Husni, S. M. Gordon, J. A. Washington, and D. L. Longworth, “Lactobacillus bacteremia and endocarditis: Review of 45 cases,” Clinical Infectious Diseases, vol. 25, no. 5, pp. 1048–1055, 1997. View at: Publisher Site | Google Scholar
  10. P. R. Murray, E. Baron, J. H. Jorgenson, M. A. Pfaller, and R. H. Yolken, ASM Press, Washington, DC, USA, 2003.

Copyright © 2018 Emily Harding-Theobald and Bharat Maraj. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

849 Views | 294 Downloads | 3 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.